Kevin J. Pridham

684 total citations
23 papers, 485 citations indexed

About

Kevin J. Pridham is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Kevin J. Pridham has authored 23 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Kevin J. Pridham's work include Extracellular vesicles in disease (3 papers), Connexins and lens biology (3 papers) and RNA modifications and cancer (3 papers). Kevin J. Pridham is often cited by papers focused on Extracellular vesicles in disease (3 papers), Connexins and lens biology (3 papers) and RNA modifications and cancer (3 papers). Kevin J. Pridham collaborates with scholars based in United States, United Kingdom and Egypt. Kevin J. Pridham's co-authors include Zhi Sheng, Robin Varghese, Robert G. Gourdie, Sujuan Guo, Jane Jourdan, Gary R. Simonds, Samy Lamouille, Susan Murphy, Pratik Kanabur and Edward D. Korn and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Cancer Research.

In The Last Decade

Kevin J. Pridham

23 papers receiving 483 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kevin J. Pridham United States 13 349 102 64 62 58 23 485
Haruka Hirose Japan 12 305 0.9× 147 1.4× 60 0.9× 69 1.1× 112 1.9× 35 579
Ivy Paw United States 5 314 0.9× 106 1.0× 67 1.0× 86 1.4× 94 1.6× 5 444
Mireia Nàger Spain 11 346 1.0× 78 0.8× 65 1.0× 59 1.0× 73 1.3× 15 480
Tracy J. Berg United States 10 279 0.8× 111 1.1× 77 1.2× 60 1.0× 125 2.2× 15 461
Cecilia Krona Sweden 15 282 0.8× 158 1.5× 54 0.8× 73 1.2× 96 1.7× 21 486
Mariam Markouli Greece 12 286 0.8× 95 0.9× 45 0.7× 66 1.1× 104 1.8× 27 469
Tércia Alves Brazil 9 246 0.7× 83 0.8× 70 1.1× 114 1.8× 67 1.2× 10 470
Nathaniel Boyd United States 9 292 0.8× 152 1.5× 68 1.1× 92 1.5× 84 1.4× 13 462
Inés Sáenz‐de‐Santa‐María Spain 13 273 0.8× 134 1.3× 40 0.6× 54 0.9× 44 0.8× 20 453
Deborah Biasoli Brazil 9 185 0.5× 78 0.8× 22 0.3× 83 1.3× 70 1.2× 14 336

Countries citing papers authored by Kevin J. Pridham

Since Specialization
Citations

This map shows the geographic impact of Kevin J. Pridham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin J. Pridham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin J. Pridham more than expected).

Fields of papers citing papers by Kevin J. Pridham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin J. Pridham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin J. Pridham. The network helps show where Kevin J. Pridham may publish in the future.

Co-authorship network of co-authors of Kevin J. Pridham

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin J. Pridham. A scholar is included among the top collaborators of Kevin J. Pridham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin J. Pridham. Kevin J. Pridham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ju, Jing, Eman Soliman, Xiaoran Wei, et al.. (2024). Immunoregulatory and neutrophil-like monocyte subsets with distinct single-cell transcriptomic signatures emerge following brain injury. Journal of Neuroinflammation. 21(1). 41–41. 6 indexed citations
2.
Pridham, Kevin J., et al.. (2024). Selective regulation of chemosensitivity in glioblastoma by phosphatidylinositol 3-kinase beta. iScience. 27(6). 109921–109921. 4 indexed citations
3.
Brickler, Thomas, Eman Soliman, Kevin J. Pridham, et al.. (2023). Endothelial deletion of EPH receptor A4 alters single-cell profile and Tie2/Akap12 signaling to preserve blood–brain barrier integrity. Proceedings of the National Academy of Sciences. 120(41). e2204700120–e2204700120. 12 indexed citations
4.
Soliman, Eman, John W. Leonard, Kevin J. Pridham, et al.. (2022). Monocyte proinflammatory phenotypic control by ephrin type A receptor 4 mediates neural tissue damage. JCI Insight. 7(15). 13 indexed citations
5.
Pridham, Kevin J., et al.. (2022). DDDR-19. NEXT-GENERATION PI3K INHIBITOR FOR GLIOBLASTOMA TREATMENT. Neuro-Oncology. 24(Supplement_7). vii102–vii102. 1 indexed citations
6.
Pridham, Kevin J., Farah Shah, Sujuan Guo, et al.. (2022). Connexin 43 confers chemoresistance through activating PI3K. Oncogenesis. 11(1). 2–2. 28 indexed citations
7.
Pridham, Kevin J., et al.. (2021). Novel Protocols for Scalable Production of High Quality Purified Small Extracellular Vesicles from Bovine Milk. Nanotheranostics. 5(4). 488–498. 43 indexed citations
8.
Cherkasova, Vera, et al.. (2021). The leucine-NH4+ uptake regulator Any1 limits growth as part of a general amino acid control response to loss of La protein by fission yeast. PLoS ONE. 16(6). e0253494–e0253494. 1 indexed citations
9.
Kang, Lin, et al.. (2020). An integrated approach to biomarker discovery reveals gene signatures highly predictive of cancer progression. Scientific Reports. 10(1). 21246–21246. 24 indexed citations
10.
Pridham, Kevin J., et al.. (2019). Functional Blockade of Small GTPase RAN Inhibits Glioblastoma Cell Viability. Frontiers in Oncology. 8. 662–662. 12 indexed citations
11.
Guo, Sujuan, Kevin J. Pridham, Ching-Man Virbasius, et al.. (2018). A large-scale RNA interference screen identifies genes that regulate autophagy at different stages. Scientific Reports. 8(1). 2822–2822. 12 indexed citations
12.
Varghese, Robin, Sarah Young, Lily Pham, et al.. (2018). Casein Kinase 1 Epsilon Regulates Glioblastoma Cell Survival. Scientific Reports. 8(1). 13621–13621. 23 indexed citations
13.
Liang, Yanping, Brian L. Gilmore, Kevin J. Pridham, et al.. (2018). Correcting errors in the BRCA1 warning system. DNA repair. 73. 120–128. 3 indexed citations
14.
Simonds, Gary R., Cara M. Rogers, Kevin J. Pridham, Zhi Sheng, & Sujuan Guo. (2017). 226 PIK3CB/p1102 is a Selective Survival Factor for Glioblastoma. Neurosurgery. 64(CN_suppl_1). 262–262. 1 indexed citations
15.
Pridham, Kevin J., Robin Varghese, & Zhi Sheng. (2017). The Role of Class IA Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunits in Glioblastoma. Frontiers in Oncology. 7. 312–312. 20 indexed citations
16.
Pridham, Kevin J., Sujuan Guo, Robin Varghese, et al.. (2017). PIK3CB/p110β is a selective survival factor for glioblastoma. Neuro-Oncology. 20(4). 494–505. 50 indexed citations
17.
Guo, Sujuan, Kevin J. Pridham, & Zhi Sheng. (2016). Detecting Autophagy and Autophagy Flux in Chronic Myeloid Leukemia Cells Using a Cyto-ID Fluorescence Spectrophotometric Assay. Methods in molecular biology. 1465. 95–109. 10 indexed citations
18.
Guo, Sujuan, Kevin J. Pridham, & Zhi Sheng. (2016). Abstract A04: LINC00467 regulates the autophagy signaling pathway STK11/AMPK. Cancer Research. 76(6_Supplement). A04–A04. 1 indexed citations
19.
Murphy, Susan, Robin Varghese, Samy Lamouille, et al.. (2015). Connexin 43 Inhibition Sensitizes Chemoresistant Glioblastoma Cells to Temozolomide. Cancer Research. 76(1). 139–149. 130 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026